Live from the NIH registry
Studies recruiting near Chula Vista right now
Top 25 of 1,262 recruiting studies, sorted by proximity — each links to its official registry page
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Phase 1
Interventional 9 participants sought
University of California, San Diego — La Jolla, California (21.4 mi)
· Sponsor: Rocket Pharmaceuticals Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Rady Children's Hospital - San Diego — San Diego, California (10.6 mi)
· Sponsor: National Cancer Institute (NCI)
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
University of California San Diego — San Diego, California (10.6 mi)
· Sponsor: Acepodia Biotech, Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — San Diego, California (10.6 mi)
· Sponsor: Sameek Roychowdhury
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of California San Diego Moores Cancer Center — San Diego, California (10.6 mi)
· Sponsor: Relay Therapeutics, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Rady Children's Hospital - San Diego — San Diego, California (10.6 mi)
· Sponsor: Medtronic MiniMed, Inc.
ATLAS-1: Advanced Trial for Longitudinal Assessment in Salma 1
Depressed Mood
N/A
Observational 5,000 participants sought
Salma Health — La Jolla, California (21.4 mi)
· Sponsor: Salma Health, Inc.
Effect of Anti-inflammatory Diet in Osteoarthritis
Osteoarthritis, Knee
N/A
Interventional 72 participants sought
University of California — San Diego, California (10.6 mi)
· Sponsor: University of California, San Diego
Targeting Minority Stressors to Improve Eating Disorder Symptoms in Sexual Minority Individuals With Eating Disorders
Eating Disorders, Sexual Minorities
Phase 1
Interventional 30 participants sought
San Diego State University — San Diego, California (10.6 mi)
· Sponsor: Auburn University
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
University of California San Diego Moores Cancer Center — San Diego, California (10.6 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — La Jolla, California (21.4 mi)
· Sponsor: AstraZeneca
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — La Jolla, California (21.4 mi)
· Sponsor: Daiichi Sankyo
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
Primary Membranous Nephropathy
Phase 2
Interventional 30 participants sought
Research Site — San Diego, California (10.6 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-San Diego Mission — San Diego, California (10.6 mi)
· Sponsor: SWOG Cancer Research Network
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
Melanoma Stage III, Melanoma Stage IV
Phase 2
Interventional 25 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (21.4 mi)
· Sponsor: University of California, San Francisco
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Colitis, Ulcerative
N/A
Observational 300 participants sought
Scripps Clinic Torrey Pines — La Jolla, California (21.4 mi)
· Sponsor: Pfizer
Automated Insulin for Management of Intrapartum Glycemia
Type 1 Diabetes (T1D), Pregnancy
N/A
Interventional 150 participants sought
University of California, San Diego — San Diego, California (10.6 mi)
· Sponsor: University of California, San Francisco
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of California, San Diego — La Jolla, California (21.4 mi)
· Sponsor: Kura Oncology, Inc.
Androgen Effects on the Reproductive Neuroendocrine Axis, 2025 Version
Transgenderism, Reproductive Issues
Phase 4
Interventional 80 participants sought
University of California, San Diego — San Diego, California (10.6 mi)
· Sponsor: University of California, San Diego
Testing the Effectiveness of an Intervention That Aligns Circadian Rhythm With Daily Activities on Student Flourishing
Chronotypes and Health
N/A
Interventional 400 participants sought
UC San Diego — La Jolla, California (21.4 mi)
· Sponsor: University of California, San Diego
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (21.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
Solid Tumor, Adult, Triple Negative Breast Cancer
Phase 1
Interventional 60 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (21.4 mi)
· Sponsor: BioEclipse Therapeutics
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
UC San Diego — La Jolla, California (21.4 mi)
· Sponsor: Cook Research Incorporated
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
The Neurology Center of Southern California - Carlsbad Office — La Jolla, California (21.4 mi)
· Sponsor: AbbVie
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Hepatocellular Carcinoma
Phase 1, Phase 2
Interventional 304 participants sought
Research Site — La Jolla, California (21.4 mi)
· Sponsor: AstraZeneca